1-oxo-1-(1-piperidinyl)-2(S)-butanamine | 80008-06-6

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 1-oxo-1-(1-piperidinyl)-2(S)-butanamine
• 英文别名: Piperidine, 1-[(2S)-2-amino-1-oxobutyl]-；(2S)-2-amino-1-piperidin-1-ylbutan-1-one
• CAS: 80008-06-6
• 化学式: C₉H₁₈N₂O
• mdl: MFCD27756457
• 分子量: 170.255
• InChiKey: ZCICKIPNYNVXMI-QMMMGPOBSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.89
• 拓扑面积：
  46.3
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• [EN] DIPEPTIDYL PEPTIDASE INHIBITORS<br/>[FR] INHIBITEURS DE DIPEPTIDYLE PEPTIDASE
  申请人：AIC

  公开号：WO2004076433A1

  公开（公告）日：2004-09-10

  The present invention relates to novel inhibitors of serine type peptidases in general and of serine type dipeptidyl peptidases in particular. The present invention further relates to the use of the dipeptidyl peptidase inhibitors for selective inhibition of dipeptidyl peptidases. The present invention also relates to pharmaceutical compositions comprising these novel dipeptidyl peptidase inhibitors. The present invention further relates to the use of the novel inhibitors in therapy, diagnosis and research.

  本发明涉及一般性的新型丝氨酸型肽酶抑制剂，特别是丝氨酸型二肽基肽酶的抑制剂。本发明还涉及利用二肽基肽酶抑制剂对二肽基肽酶进行选择性抑制。本发明还涉及包含这些新型二肽基肽酶抑制剂的药物组合物。本发明还涉及在治疗、诊断和研究中使用这些新型抑制剂。
• KDM1A inhibitors for the treatment of disease
  申请人：Imago Biosciences, Inc.

  公开号：US10882835B2

  公开（公告）日：2021-01-05

  Disclosed herein are new compounds and compositions and their application as pharmaceuticals for the treatment of diseases. Methods of inhibition of KDM1A, methods of increasing gamma globin gene expression, and methods to induce differentiation of cancer cells in a human or animal subject are also provided for the treatment of diseases such as acute myelogenous leukemia.

  本文公开了新化合物和组合物及其作为药物治疗疾病的应用。还提供了抑制 KDM1A 的方法、增加γ 球蛋白基因表达的方法以及诱导人或动物体内癌细胞分化的方法，用于治疗急性髓性白血病等疾病。
• US9790195B2
  申请人：——

  公开号：US9790195B2

  公开（公告）日：2017-10-17
• [EN] DIPEPTIDYL PEPTIDASE INHIBITORS<br/>[FR] INHIBITEURS DE DIPEPTIDYL PEPTIDASES
  申请人：AIC

  公开号：WO2004076434A1

  公开（公告）日：2004-09-10

  The present invention relates to novel inhibitors of serine type peptidases in general and of serine type dipeptidyl peptidases in particular. The present invention further relates to the use of the dipeptidyl peptidase inhibitors for selective inhibition of dipeptidyl peptidases. The present invention also relates to pharmaceutical compositions comprising these novel dipeptidyl peptidase inhibitors. The present invention further relates to the use of the novel inhibitors in therapy, diagnosis and research.